🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 55% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

37 mL Serving Size
2 Servings
Other Combinations Product Type
55% Evidence Coverage

Supplement Facts — Evidence Check

Calories
5 Calorie(s)
Total Carbohydrates
1 Gram(s) (1% DV)
5 mg (25% DV)
✅ Within RDA (0.4× RDA of 14 mg) 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 5mg UL 35mg
50 mcg (37% DV)
📊 Market median: 10.0mg (1576 products) 📚 113 studies (Tier A: 3, B: 35)
RDA 1.3mg This product: 0.05mg UL 100mg
100 mcg (50% DV)
✅ Within RDA (0.2× RDA of 0.4 mg) 📚 225 studies (Tier A: 10, B: 105)
RDA 0.4mg This product: 0.1mg UL 1.0mg
25 mg (8333% DV)
📊 10416.7× RDA — above typical dose 📚 138 studies (Tier A: 1, B: 44)
RDA 0.0024mg This product: 25mg
Potassium
40 mg (1% DV)
📊 Market median: 180.0mg (239 products) 📚 43 studies (Tier A: 1, B: 19)
This product: 200mg UL 400mg
📊 Market median: 500.0mg (223 products) 📚 22 studies (Tier A: 0, B: 1)
This product: 100mg
DL-Phenylalanine
50 ng
Mr Hyde Amino Blend
101 mg

Other Ingredients

purified Water Glycerin Natural & Artificial flavor Citric Acid Malic Acid Sucralose Acesulfame Potassium Potassium Sorbate Phosphoric Acid Sodium Benzoate FD&C Blue #1

Label Claims — Verification

All Other
All Other (97% of products) Structure/Function (86% of products) Nutrient (36% of products)

Target Groups

Adult (18 - 50 Years) Sugar Free

Product Information

📋 Directions for Use

This is a two dose shot. Please take half to asses tolerance.

Suggested use: Begin with one-half shot (1.25 fl. oz.) of Mr. Hyde Energy to assess tolerance. Never exceed more than one half (1/2) shot per 12 hours or one full shot daily. One half (1/2) shot is equal to one full serving.

Use or discard contents within 48 hours of opening.

Shake well

⚠️ Warnings & Precautions

Never exceed more than one half (1/2) shot per 12 hours or one full shot daily. One half (1/2) shot is equal to one full serving. Do not consume with other caffeinated products.

Caution: Contains caffeine comparable to 16 oz of the leading premium coffee. Limit caffeine products to avoid nervousness, sleeplessness, or an occasional rapid heartbeat.

🧪 Formulation Notes

Intense energy shot+

Sugar free+

Product Details

DSLD Entry Date 2021-07-27
Product Type Other Combinations
Form Liquid
Brand ProSupps
DSLD ID 252015
Data Updated 2026-04-11

Research Evidence

241 Research Sources
55 Avg Quality Score
113 Meta Analysis
75 Systematic Review
32 Rct
11 Clinical Trial
3 Other
3 Regulatory Source
1 Cochrane Review
1 Narrative Review
1 Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016
View all evidence for Niacin →

Compare Similar Products

View all Niacin products →